AUGX Stock Analysis
AU
Uncovered
Augmedix Inc is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Augmedix, Inc. engages in the development of software that converts natural clinician-patient conversations into medical documentation. The company is headquartered in San Francisco, California and currently employs 706 full-time employees. The company went IPO on 2021-03-04. The firm Ambient Automation Platform converts the natural conversation between physicians and patients into timely and medical notes and provides a suite of related services. Its platform uses automatic speech recognition, natural language processing and clinical datasets to capture the ambient visit conversation and generate a structured medical note. The structured medical note data is then used to deliver additional data services. The devices that the Company provides to clinicians can be used to capture telemedicine visits regardless of the telehealth platform used by the clinician. The firm provides services from nine medical documentation specialists (MDS) operations centers across four countries: the United States, Bangladesh, India and Sri Lanka.